Alejandro Patino - Genomma Lab President

LABB Stock  MXN 15.78  0.27  1.74%   

President

Mr. Alejandro Baston Patino serves as VicePresident of International and Sales Development of Genomma Lab Internacional, S.A.B. de C.V. since 2015. He joined in the Company as Vice President of Commercial Strategy in 2008. Between 2007 and 2008, he has served as Chief Executive Officer of Depilite, and from 1999 to 2007, he acted as Director of Sales of OCESA. In the past, he worked at Hotel InterContinental, Hotel Stouffer Presidente, Hotel Las Brisas, Hoteles Camino Real and Hoteles Westin. He holds a diploma in Advanced Management and Sales from Insitituto Tecnologico y de Estudios Superiores de Monterrey and has attended to courses in Marketing and Business at the Cornell University and University of California, Berkeley. since 2015.
Age 51
Tenure 9 years
Phone52 55 5081 0000
Webhttps://www.genommalab.com

Genomma Lab Management Efficiency

The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1264 %, meaning that it generated $0.1264 on every $100 dollars invested by stockholders. Genomma Lab's management efficiency ratios could be used to measure how well Genomma Lab manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 3.83 B in total debt with debt to equity ratio (D/E) of 0.61, which is about average as compared to similar companies. Genomma Lab Internacional has a current ratio of 1.72, which is within standard range for the sector. Debt can assist Genomma Lab until it has trouble settling it off, either with new capital or with free cash flow. So, Genomma Lab's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genomma Lab Internacional sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genomma to invest in growth at high rates of return. When we think about Genomma Lab's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Susan ChambersWalmart
57
William LennieThe Home Depot
63
Matthew CareyThe Home Depot
58
Mark TrittonTarget
53
Mark HolifieldThe Home Depot
62
Robert HarrisonTarget
N/A
Shelley ReynoldsAmazon Inc
58
Marc PowersThe Home Depot
52
Don LiuTarget
61
Patrick GrismerStarbucks
56
Jill WalkerStarbucks
46
Minsok PakTarget
48
Edward DeckerThe Home Depot
60
John CulverStarbucks
63
Rachel RuggeriStarbucks
53
Jason GoldbergerTarget
N/A
Jeffrey BlackburnAmazon Inc
48
David ZapolskyAmazon Inc
59
M BiggsWalmart
50
Suresh KumarWalmart
58
Rollin FordWalmart
52
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people. Genomma Lab Internacional (LABB) is traded on Mexican Exchange in Mexico and employs 2,297 people.

Management Performance

Genomma Lab Internacional Leadership Team

Elected by the shareholders, the Genomma Lab's board of directors comprises two types of representatives: Genomma Lab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genomma. The board's role is to monitor Genomma Lab's management team and ensure that shareholders' interests are well served. Genomma Lab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genomma Lab's outside directors are responsible for providing unbiased perspectives on the board's policies.
Maximo Juda, CEO, COO and Executive Vice-Pres
Scott Emerson, Independent Director
Stefano Curti, Global President of Brands
Cesar Lopez, Vice President of Global Marketing
Efran Crdova, Deputy Sec
Ramon Sastre, Executive Vice President of Institutional Relations
Carlos Alonso, Independent Director
Marianne Velasco, Global HR
Marco Munoz, Non-Member Secretary of the Board of Directors
Jorge Munoz, Independent Director
Ignacio Rodriguez, Independent Director
Alejandro Patino, Executive Vice President of Human Capital and Commercial Expansion
L Porres, Legal Officer
Leandro Gold, Independent Director
Jose Fernandez, Independent Director
Rodrigo Aspra, Chairman of the Board, Independent Director
Claudia Vettoretti, Vice-President of Marketing
Renata Aspra, COO and Executive Vice-Pres
Juan Gavito, Independent Director
Antonio Galland, Executive Vice President, Chief Financial and Chief Administrative Officer
Luis MacKissack, Director
Arturo Perez, Director
Hector Gonzalez, Independent Director
Burkhard Wittek, Director
Alejandro Patio, Media, Relations
Marco Sparvieri, Executive Vice-President of Global Sales
Javier Castilla, Independent Director
Engineer Galland, Exec CFO
Sabrina Aspra, Director of International Operations, Director
Mximo Juda, Advisor
Daniel Neria, Head Relations
Juan Alonso, Independent Director
Santiago Pelaez, Vice President of Industrial and Research and Development
Jorge Valderrama, Chief Executive Officer
Juan Sparvieri, Chief Operating Officer, Vice President
Roberto Sauma, Independent Director
Leticia Herrera, Global Director of Human Resources (Genomma Experience)

Genomma Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genomma Lab a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Genomma Stock analysis

When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Please note, there is a significant difference between Genomma Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genomma Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genomma Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.